Department of Anaesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100878. doi: 10.1016/j.accpm.2021.100878. Epub 2021 May 5.
Sevoflurane has been used to induce anaesthesia in adults due to its suitability for airway management and haemodynamic stability. Few studies have reported arrhythmia during volatile induction with sevoflurane in adults. Here, we investigated the incidence of arrhythmia and risk factors associated with its occurrence during sevoflurane induction of anaesthesia in adults.
We retrospectively analysed 950 adult patients who underwent elective ear nose and throat surgery with volatile induction using sevoflurane between May and December 2015. The incidence of arrhythmia and the factors associated with its development were analysed.
Arrhythmia was observed in 164 (17.3%) of 950 adult patients. The most frequently observed arrhythmia was sinus tachycardia (heart rate > 120 bpm) (77 patients, 47.0%). The multivariable logistic analysis showed four independent risk factors: age (odds ratio [OR] = 0.984, 95% confidence interval [CI] = 0.973-0.996, p = 0.006), coronary artery disease (OR = 3.749, 95% CI = 1.574-8.927, p = 0.003), maximal concentration (8 vol%) of sevoflurane from the start of induction (OR = 2.696, 95% CI = 1.139-6.382, p = 0.024), and maintenance of 8 vol% sevoflurane concentration after eyelash reflex loss (OR = 1.577, 95% CI = 1.083-2.296, p = 0.018). The risk of hypotension was greater in patients in whom arrhythmia occurred, although blood pressure recovered to baseline after the concentration of sevoflurane was adjusted.
We recommend that the sevoflurane concentration be gradually increased with continuous and vigilant electrocardiogram and blood pressure monitoring. The sevoflurane concentration should be adjusted after sufficient unconsciousness is reached.
七氟醚因其适合气道管理和血液动力学稳定而被用于成人全身麻醉的诱导。很少有研究报道成人使用七氟醚诱导挥发性麻醉时出现心律失常。在此,我们研究了成人全身麻醉使用七氟醚诱导时心律失常的发生率及相关危险因素。
我们回顾性分析了 2015 年 5 月至 12 月期间,950 例在全身麻醉下使用七氟醚行择期耳鼻喉手术的成年患者。分析心律失常的发生率和与之相关的发展因素。
950 例成年患者中,164 例(17.3%)出现心律失常。最常见的心律失常是窦性心动过速(心率>120bpm)(77 例,47.0%)。多变量逻辑分析显示四个独立的危险因素:年龄(比值比[OR] = 0.984,95%置信区间[CI] = 0.973-0.996,p = 0.006)、冠状动脉疾病(OR = 3.749,95% CI = 1.574-8.927,p = 0.003)、诱导开始时 8%七氟醚最大浓度(OR = 2.696,95% CI = 1.139-6.382,p = 0.024)和睫毛反射消失后维持 8%七氟醚浓度(OR = 1.577,95% CI = 1.083-2.296,p = 0.018)。尽管在调整七氟醚浓度后血压恢复至基线,但发生心律失常的患者出现低血压的风险更大。
我们建议在连续、警惕地监测心电图和血压的情况下,逐渐增加七氟醚浓度。在达到充分的无意识状态后,应调整七氟醚浓度。